UniProt/SwissProt ID: | 2AAA_HUMAN |
Description: | protein phosphatase 2, regulatory subunit A, alpha [Source:HGNC Symbol;Acc:9302] |
Location: | chr19 q13.41 |
Node attribute: | substrate |
Phosphorylation site |
Position | PhosphoPeptide | Catalytic kinase | Source |
---|---|---|---|
S335 | IKELVsDANQH | PhosphoSitePlus; HPRD | |
S343 | NQHVKsALASV | PhosphoSitePlus | |
T584 | AQEALtVLSLA | HEAT | PhosphoSitePlus |
S9 | ADGDDsLYPIA | PhosphoSitePlus; HPRD; SysPTM | |
S554 | PILDNsTLQSE | PhosphoSitePlus | |
Dephosphorylation site |
2AAA_HUMAN do not have dephosphorylation site. |
Mutation site |
Ensembl ID | Variation | Source | Cancer name | Pubmed |
---|---|---|---|---|
ENSP00000324804 | R249H | COSMIC | Uterine Cancer | 21381030 |
ENSP00000324804 | T145P | COSMIC | Ovarian Cancer | 21720365 |
ENSP00000324804 | R258C | COSMIC | Ovarian Cancer | 21381030 |
ENSP00000324804 | R183W | TCGA | Ovarian Cancer | 21720365, 18772890 |
ENSP00000324804 | E64G | COSMIC | Breast Cancer | 10713707 |
ENSP00000324804 | D375fs*8 | COSMIC | Renal Cancer | 20054297 |
ENSP00000324804 | S256F | COSMIC | Uterine Cancer | 21381030 |
ENSP00000324804 | V201I | BIOMART | Breast Cancer | 21930507, 21930502 |
ENSP00000324804 | R260C | COSMIC | Ovarian Cancer | 21720365 |
ENSP00000324804 | R183W | COSMIC | Uterine Cancer | 21381030 |
ENSP00000324804 | W257C | TCGA | Ovarian Cancer | 21720365, 18772890 |
ENSP00000324804 | R418W | COSMIC | Melanoma | 10713707 |
ENSP00000324804 | W257G | COSMIC | Uterine Cancer | 21381030 |
ENSP00000324804 | E393Q | COSMIC | Lung Cancer | 20668451 |
ENSP00000324804 | R260C | TCGA | Ovarian Cancer | 21720365, 18772890 |
ENSP00000324804 | R182W | COSMIC | Uterine Cancer | 21381030 |
ENSP00000324804 | P179L | COSMIC | Uterine Cancer | 21381030 |
Differential expressed protein |
Ensembl ID | Cancer name | Design | Sample | Change | Ratio | Pubmed |
---|---|---|---|---|---|---|
ENSP00000324804 | Esophageal Cancer | Normal vs. Cancer | tissue | Down | 0.43 | 19142970 |
ENSP00000324804 | Esophageal Cancer | Normal vs. Cancer | tissue | Down | 0.44 | 19142970 |
ENSP00000324804 | Melanoma | Treatment (none vs. kojic acid treatment) | cell line | Up | 1.5 | 18630942 |
ENSP00000324804 | Gastric Cancer | Normal vs. Cancer | tissue | Down | 0.53 | 15761955 |
Hyperphosphorylation site |
2AAA_HUMAN do not have hyperphosphorylation site. |
Direct Interaction Pair |
Source | Target | Relationship | Resource |
---|---|---|---|
KS6A3_HUMAN | 2AAA_HUMAN | kinase -> substrate | Robert H Newman (2013) |
BTK_HUMAN | 2AAA_HUMAN | kinase -> substrate | Robert H Newman (2013) |
AAPK1_HUMAN | 2AAA_HUMAN | kinase -> substrate | Robert H Newman (2013) |
PKN1_HUMAN | 2AAA_HUMAN | kinase -> substrate | Robert H Newman (2013) |
MK08_HUMAN | 2AAA_HUMAN | kinase -> substrate | Robert H Newman (2013) |
LATS1_HUMAN | 2AAA_HUMAN | kinase -> substrate | Robert H Newman (2013) |
Function Annotation |
KEGG Pathway |
2AAA_HUMAN is not in KEGG pathway. |
Gene Ontology |
GO ID | GO_Term | Evidence | Ontology |
---|---|---|---|
GO:0030155 | regulation of cell adhesion | NAS | biological_process |
GO:0005634 | nucleus | NAS | cellular_component |
GO:0006355 | regulation of transcription, DNA-dependent | NAS | biological_process |
GO:0006461 | protein complex assembly | TAS | biological_process |
GO:0015630 | microtubule cytoskeleton | NAS | cellular_component |
GO:0005739 | mitochondrion | NAS | cellular_component |
GO:0006672 | ceramide metabolic process | NAS | biological_process |
GO:0003823 | antigen binding | IPI | molecular_function |
GO:0000278 | mitotic cell cycle | TAS | biological_process |
GO:0016020 | membrane | NAS | cellular_component |
GO:0005515 | protein binding | IPI | molecular_function |
GO:0016070 | RNA metabolic process | TAS | biological_process |
GO:0008380 | RNA splicing | NAS | biological_process |
GO:0000188 | inactivation of MAPK activity | NAS | biological_process |
GO:0005829 | cytosol | IEA | cellular_component |
GO:0046982 | protein heterodimerization activity | IPI | molecular_function |
GO:0016071 | mRNA metabolic process | TAS | biological_process |
GO:0000159 | protein phosphatase type 2A complex | IEA | cellular_component |
GO:0004722 | protein serine/threonine phosphatase activity | IEA | molecular_function |
GO:0030111 | regulation of Wnt receptor signaling pathway | NAS | biological_process |
GO:0019932 | second-messenger-mediated signaling | NAS | biological_process |
GO:0070262 | peptidyl-serine dephosphorylation | IEA | biological_process |
GO:0007059 | chromosome segregation | IDA | biological_process |
GO:0010467 | gene expression | TAS | biological_process |
GO:0006470 | protein dephosphorylation | TAS | biological_process |
GO:0006917 | induction of apoptosis | TAS | biological_process |
GO:0010033 | response to organic substance | NAS | biological_process |
GO:0005488 | binding | IEA | molecular_function |
GO:0008543 | fibroblast growth factor receptor signaling pathwa | TAS | biological_process |
GO:0000086 | G2/M transition of mitotic cell cycle | TAS | biological_process |
GO:0045595 | regulation of cell differentiation | NAS | biological_process |
GO:0008601 | protein phosphatase type 2A regulator activity | TAS | molecular_function |
GO:0000775 | chromosome, centromeric region | IDA | cellular_component |
GO:0006275 | regulation of DNA replication | NAS | biological_process |
GO:0005515 | protein binding | IEA | molecular_function |
GO:0030308 | negative regulation of cell growth | NAS | biological_process |
GO:0040008 | regulation of growth | NAS | biological_process |
GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsen | TAS | biological_process |
GO:0042981 | regulation of apoptotic process | IEA | biological_process |
GO:0042518 | negative regulation of tyrosine phosphorylation of | NAS | biological_process |
GO:0005829 | cytosol | TAS | cellular_component |
GO:0000159 | protein phosphatase type 2A complex | TAS | cellular_component |